There were 33 press releases posted in the last 24 hours and 170,732 in the last 365 days.

Colorectal Cancer Therapeutics Market to reach USD 16.58 billion by 2026, Presence of Strong Oncology Portfolio to help Players Gain Competitive: Reports Fortune Business Insights™

Key Companies Covered in the Colorectal Cancer Therapeutics Market Research Report are Novartis AG, Bayer AG, Merck Sharp & Dohme Corp., Bristol Myers Squibb, Pfizer Inc., Genentech, Inc., Ipsen Biopharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.), Sanofi, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company and other key market players.

/EIN News/ -- Pune, Jan. 14, 2020 (GLOBE NEWSWIRE) -- The global Colorectal Cancer Therapeutics Market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights™ titled, “Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026,” provides a detailed analysis of the same.

According to the report, the colorectal cancer drugs market was valued at USD 9.26 billion in 2018. The forecast period is set from 2019 to 2026, and the market is likely to exhibit a CAGR of 7.6%. As per current Colorectal Cancer Therapeutics Market trends, the targeted therapy segment is dominating the market in terms of therapy. This is attributed to the presence of a large number of prominent targeted cancer therapies such as Stivarga, Erbitux, and Avastin.


For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/colorectal-cancer-therapeutics-market-101945


The report offers a comprehensive overview of the Colorectal Cancer Therapeutics Market analysis and its growth trajectories such as drivers, restraints, challenges, and opportunities. Besides that, the report provides a detailed segmentation of the market based on factors such as cancer type, by therapy, distribution channel, and others. It also offers the list of key colorectal cancer drugs market manufacturers and the prime strategies adopted by them to gain a competitive edge in the market.

Launch of Better Therapeutics for Colorectal Cancer to Aid in Expansion of Market

The rise in awareness about colorectal cancer is a major factor driving the Colorectal Cancer Therapeutics Market growth. Additionally, the increasing number of corresponding product launches for effective colorectal cancer treatment is further expected to help increase the overall market growth in the forecast period. Moreover, the advent of the latest initiatives aiming to provide effective care of colorectal cancer patients is more likely to aid in the expansion of the market for colorectal cancer drugs.  Furthermore, the high mortality rates, coupled with the rising demand for effective cancer therapeutics worldwide, is prognosticated to have a positive effect on the colorectal cancer medications market size in the forthcoming years.

Rise in Disposable Incomes and Increasing Awareness about Therapeutic Procedures to Help Asia Pacific Witness Rapid Growth

Geographically, North America is leading the market with a high prevalence of colorectal cancer. In 2018, North America earned USD 4.13 billion, owing to the new product launches in and around the region. Thus, the factors mentioned above are likely to help this region continue dominating the market in the future too.

On the other side, the continuously improving healthcare infrastructure, coupled with the rise in disposable incomes of people in Asia Pacific is expected to boost the regional market in the forecast period. Colorectal cancer is a major reason for the rise in mortality rates, coupled with the rising awareness about colorectal cancer therapeutics that will help this region attract high Colorectal Cancer Therapeutics Market revenue in the near future.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/colorectal-cancer-therapeutics-market-101945


Merck Sharp & Dohme Corp, Genentech, Inc., and Bristol Myers Squibb Holding Leading Market Position

Major vendors in the Colorectal Cancer Therapeutics Market are focusing on research and development of novel colorectal cancer therapeutics. Currently, companies such as Bristol Myers Squibb, Genentech, Inc., and Merck Sharp & Dohme Corp are dominating the market. This is owing to the robust pipeline candidates, key strategic decisions, and the presence of a strong oncology portfolio. The overall Colorectal Cancer Therapeutics Market is subject to a number of biosimilar launches and has a strong presence of generics, especially for chemotherapy.

Some of the key industry developments in the Colorectal Cancer Therapeutics Market are:

July 2019 – Pfizer, a key player in the market for colorectal cancer medications, completed the acquisition of Array BioPharma Inc., for strengthening the oncology pipeline for colorectal cancer treatment.

July 2019 – Allergan and Amgen launched the first anticancer biosimilars Kanjinti and Mvasi, in the U.S. These biosimilars are used for treating colorectal cancer.


List of The Key Players Operating in the
Colorectal Cancer Drugs Market Include:

  • Novartis AG
  • Bayer AG
  • Merck Sharp & Dohme Corp.
  • Bristol Myers Squibb
  • Pfizer Inc.
  • Genentech, Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Taiho Pharmaceutical (Otsuka Pharmaceutical Co., Ltd.)
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly and Company


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/colorectal-cancer-therapeutics-market-101945


Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Colorectal Cancer - By Key Countries, 2018
    • Pipeline Analysis, Key Players
    • Key Industry Developments
    • New Product Launches
    • Increasing R&D Initiatives in Colorectal Cancer Diagnostics
  • Global Colorectal Cancer Therapeutics Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Therapy
      • Targeted Therapy
      • Immunotherapy
      • Chemotherapy
      • Others
    • Market Analysis, Insights and Forecast – By Cancer Type
      • Colorectal Adenocarcinoma
      • Gastrointestinal Carcinoid Tumors
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa

TOC Continued….!


Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/colorectal-cancer-therapeutics-market-101945


Have a Look at Related Reports:

Lung Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted, Therapy, Immunotherapy, Chemotherapy), By Cancer Type (Non-small cell lung cancer (NSCLC), Small cell lung cancer (SCLC)), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026

Non-Small Cell Lung Cancer Therapeutics Market Size, Share and Global Trend by Therapy (Targeted Therapy, Immunotherapy, Chemotherapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Cancer Type (Adenocarcinoma, Squamous cell carcinoma, Large cell carcinoma), Geography Forecast till 2026

Genomics Market Size, Share and Global Trend By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing), Application (Diagnostics, Research), End-User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)) & Geography Forecast till 2026

Regenerative Medicine Market Size, Share and Global Trend By By Product (Cell Therapy, Gene Therapy, Tissue Engineering, Platelet Rich Plasma), By Application (Orthopaedics, Wound Care, Oncology), By Distribution Channel (Hospitals, Clinics) & Geography Forecast till 2026

Breast Cancer Therapeutics Market Size, Share and Industry Analysis By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Cancer Type (Hormone Receptor, HER2+), and Regional Forecast, 2019 - 2026

Orphan Drugs Market Size, Share and Industry Analysis By Therapy Area (Oncology, Blood, CNS, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales) and Regional Forecast, 2018 – 2025

Molecular Diagnostics Market Size, Share and Industry Analysis By Product Type (Instruments Reagents & Consumables), By Application (Infectious Disease, Blood Screening, Histology & Oncology), By Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs), and Regional Forecast 2018-2025

Dialyzer Market Size, Share and Industry Analysis by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Regional Forecast, 2019 – 2026

Thrombin Market Size, Share and Industry Analysis By Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin), By Dosage Form (Powder Form, Solution Form), By End user (Hospitals, Diagnostics Centers & Clinics, Academics and Research Institutes), and Regional Forecast, 2019 - 2026

Rheumatoid Arthritis Therapeutics Market Size, Share and Industry Analysis By Product Type (Biologics, Non-Biologics), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast 2018-2025

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release https://www.fortunebusinessinsights.com/press-release/colorectal-cancer-therapeutics-market-9505

Primary Logo


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.